PSA Today Mar 29: Good end to sour week / Macro mixed / AZN buys into DSK's DS- 8201 / Are Japan's high flyers having cost control issues? / ZOZO's bank loans – Nikkei +0.82%
Japan Market Comment by Pelham Smithers and Thao NguyenNikkei ¥21,205.81(+¥172.05 / +0.82%); Topix ¥1,591.64 (+¥8.79 / +0.56%); ¥/$110.74
Tags: Daiichi Sankyo (4568 JT), AstraZeneca (AZN LN), Eisai (4523 JT), Merck (MRK US), Rakuten (4755 JT), Lyft (LYFT US), Yume no Machi Souzou Iinkai (2484 JT), Just Eat (JE/ LN), Takeda (4502 JT), Ono Pharm (4528 JT), Bristol-Myers Squibb (BMY US), Kitanotatsujin (2930 JT), ZOZO (3092 JT), Sumitomo Mitsui Banking Corporation (pvt.), The ChibaBank, Ltd. (8331 JT), The Keiyo Bank, Ltd. (8544 JT)
Main Points
• Tokyo ends sour week on positive note
• Another round of “glass not quite half full†economic data
• AZN buys into DSK’s DS-8201
• Are there cost control issues at Japan’s high fliers?
• ZOZO to receive a ¥15bil loan
Founded in 2009, Pelham Smithers Associates (PSA) provides market intelligence on Asian technology, focusing in particular on Japan. The industries covered by our team of specialists are: consumer electronics, telecomms, pharmaceuticals, internet, electronic parts and materials, automotive technology, retail and capital goods.
PSA produces both company and sector reports. The focus of PSA’s research is to identify winners and losers as new technologies impact the top and bottom lines of corporations. Critical to our research is the clear explanation of how these new technologies work and how they impact companies and industries.
The founding partners have worked closely together for twenty years and the team has more than doubled in size since 2012.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.